A Case Controlled Etiologic Study of Sarcoidosis (ACCESS)

Note that you will be prompted to log in or register an account

Accession Number
HLB00300404a

Study Type
Epidemiology Study

Collection Type
Open BioLINCC Study See bottom of this webpage for request information

Study Period
June 1995 - March 2003

NHLBI Division
DLD

Dataset(s) Last Updated
July 17, 2020

Primary Publication URLs
N/A

Consent

Commercial Use Data Restrictions No

Data Restrictions Based On Area Of Research No

Commercial Use Specimen Restrictions No

Non-Genetic Use Specimen Restrictions Based On Area Of Use Yes

Genetic Use Of Specimens Allowed? Yes

Genetic Use Area Of Research Restrictions Yes

Specific Consent Restrictions
Biospecimen research is restricted to studies related to sarcoidosis. Use of data is unrestricted.

Objectives

To determine the etiology of sarcoidosis by establishing a case control, multi-center study. In addition to etiology, this study also sought to examine socioeconomic variables and the clinical course of patients with sarcoidosis, including quality of life.

Background

Sarcoidosis is a chronic granulomatous disorder of unknown cause that is characterized by activation of T-lymphocytes and macrophages. For many years sarcoidosis was presumed to be an atypical manifestation of tuberculosis because of the similarity between the inflammatory responses of the two diseases. However, as culture techniques became more widely employed to diagnose tuberculosis and it became less common, it became clear that sarcoidosis was not simply a variation of tuberculosis. Data on the etiology of sarcoidosis have come from diverse sources: in clinical investigations, alveolitis has been found to precede granulomatous inflammation; in case control studies, familial aggregation has been identified; and in case reports, recurrence of granulomatous inflammation has been observed after lung transplantation. The cause may not prove to be a single, known exposure. Interactions of exposures with genetic dispositions could have important implications for our understanding of immune responses as well as the pathogenesis of sarcoidosis.

Participants

736 patients with sarcoidosis enrolled within 6 months of diagnosis from 10 clinical centers in the U.S. Using the ACCESS sarcoidosis assessment system, organ involvement was determined for the whole group and for subgroups differentiated by sex, race, and age (<40 or 40 and older). Cases were matched with a control, and there was a two-year follow-up on cases. The ACCESS group proposed an instrument fo defining organ involvement in sarcoidosis. Biological specimens included DNA, plasma, and bronchoalveolar lavage samples were obtained. The data set includes 718 cases, 686 controls, and two-year follow-up data on 241 cases.

Conclusions

The initial presentation of sarcoidosis is related to sex, race and age, and it tends to remain stable over two years in the majority of patients. The etiology is probably multifactoral with both genetic and environmental factors contributing.

Specimen Details

The PBMC for this study are pelleted and suspended in guanidinium-based solution and are nonviable.

Additional Details

Subjects:

Cases: 718

Controls: 686

Age:

 

Control

Case

All

N

%

N

%

N

%

18-29

75

10.93

80

11.14

155

11.04

30-39

222

32.36

247

34.40

469

33.40

40-49

224

32.65

214

29.81

438

31.20

50-59

118

17.20

129

17.97

247

17.59

>=60

47

6.85

48

6.69

95

6.77

 
Sex:

 

Control

Case

All

N

%

N

%

N

%

Male

243

35.42

261

36.35

504

35.90

Female

443

64.58

457

63.65

900

64.10

 
Race:

 

Control

Case

All

N

%

N

%

N

%

White

380

55.39

393

54.74

773

55.06

Black

306

44.61

325

45.26

631

44.94

 

Please note that biospecimen availability is subject to review by the NHLBI, BioLINCC, and the NHLBI Biorepository. Certain biospecimens may not be made available for your request. Section 3 of the BioLINCC handbook describes the components of the review process

Visits (Vials):

03/15/2022

  Plasma DNA PBMC Bronchial Lavage Total
1 Visit per Subject 12,602 29,683 1,394 593 44,272
Visits (Subjects):

03/15/2022

  Plasma
Total number of subjects Average volume (ml) per subject
1 Visit per Subject 1,423 12.37
 
  Bronchial Lavage
Total number of subjects Average volume (ml) per subject
1 Visit per Subject 73 5.25
 
  PBMC
Total number of subjects Average vials per subject
1 Visit per Subject 1,218 1.14
 
  DNA
Total number of subjects Average mass (ug) per subject Average vials per subject
1 Visit per Subject 1,426 109.19 13.02

 

Please note that researchers must be registered on this site to submit a request, and you will be prompted to log in. If you are not registered on this site, you can do so via the Request button. Registration is quick, easy and free.

Resources Available

Specimens and Study Datasets

Materials Available

  • Bronchial Lavage
  • DNA
  • Peripheral Blood Mononuclear Cells
  • Plasma
  • More Details

Study Documents

Persons using assistive technology may not be able to fully access information in the study documents. For assistance, Contact BioLINCC and include the web address and/or publication title in your message. If you need help accessing information in different file formats such as PDF, XLS, DOC, see Instructions for Downloading Viewers and Players.